I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Vidlin, Sara Hedfors
11
results:
Search for persons
X
Format
Online (11)
Mediatypes
Articles (Online) (5)
OpenAccess-fulltext (6)
Sorted by: Relevance
Sorted by: Year
?
1
Supporting Pharmacovigilance Signal Validation and Prioriti..:
Gauffin, Oskar
;
Brand, Judith S.
;
Vidlin, Sara Hedfors
...
Drug Safety. 46 (2023) 12 - p. 1335-1352 , 2023
Link:
https://doi.org/10.1007/..
?
2
Remdesivir in the COVID-19 Pandemic: An Analysis of Spontan..:
Rocca, Elena
;
Gauffin, Oskar
;
Savage, Ruth
..
Drug Safety. 44 (2021) 9 - p. 987-998 , 2021
Link:
https://doi.org/10.1007/..
?
3
Sex Differences in Reported Adverse Drug Reactions to COVID..:
Zekarias, Alem
;
Watson, Sarah
;
Vidlin, Sara Hedfors
.
Drug Safety. 43 (2020) 12 - p. 1309-1314 , 2020
Link:
https://doi.org/10.1007/..
?
4
A Feasibility Study of Drug–Drug Interaction Signal Detecti..:
Hult, Sara
;
Sartori, Daniele
;
Bergvall, Tomas
...
Drug Safety. 43 (2020) 8 - p. 775-785 , 2020
Link:
https://doi.org/10.1007/..
?
5
Prospective Evaluation of Adverse Event Recognition Systems..:
Gattepaille, Lucie M.
;
Hedfors Vidlin, Sara
;
Bergvall, Tomas
..
Drug Safety. 43 (2020) 8 - p. 797-808 , 2020
Link:
https://doi.org/10.1007/..
?
6
Supporting Pharmacovigilance Signal Validation and Prioriti..:
Gauffin, Oskar
;
Brand, Judith S
;
Vidlin, Sara Hedfors
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684396/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
7
Supporting Pharmacovigilance Signal Validation and Prioriti..:
Gauffin, Oskar
;
Brand, Judith S
;
Vidlin, Sara Hedfors
...
European Health Data and Evidence Network (EHDEN) [grant agreement No 806968]. , 2023
Link:
https://vinar.vin.bg.ac...
?
8
Remdesivir in the COVID-19 Pandemic: An Analysis of Spontan..:
Rocca, Elena
;
Gauffin, Oskar
;
Savage, Ruth
..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353611/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
9
Sex Differences in Reported Adverse Drug Reactions to COVID..:
Zekarias, Alem
;
Watson, Sarah
;
Vidlin, Sara Hedfors
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518652/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
10
A Feasibility Study of Drug–Drug Interaction Signal Detecti..:
Hult, Sara
;
Sartori, Daniele
;
Bergvall, Tomas
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395907/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
11
Prospective Evaluation of Adverse Event Recognition Systems..:
Gattepaille, Lucie M
;
Hedfors Vidlin, Sara
;
Bergvall, Tomas
..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395913/. , 2020
Link:
http://www.ncbi.nlm.nih...
1-11
